Cover Image
Market Research Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

Published by GlobalData Product code 917873
Published Content info 144 Pages
Delivery time: 1-2 business days
Price
Back to Top
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
Published: November 29, 2019 Content info: 144 Pages
Description

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The Philippines healthcare market is one of the major emerging markets in the world, with a strong focus on research and development (R&D). The Philippines pharmaceutical market increased from ?128B in 2011 to ?176B in 2018 at a Compound Annual Growth Rate (CAGR) of 4.65%. In terms of US dollars, the pharmaceutical market was $2.96B in 2011, which increased to $3.34B in 2018 at a CAGR of 1.75%. The Philippines medical device market was valued at $196.18M in 2015, which increased to $227.10M in 2018. The Philippines pharmaceutical and medical device market is import-driven.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Unilab, Pfizer, GSK, Boehringer and Sanofi) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Fresenius Medical Care, Siemens Healthineers, and Philips Healthcare.)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Philippines
  • Porter's five forces analysis for pharmaceutical and medical devices market of Philippines
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding the health-tech landscape of the country along with the major health-tech deals
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Philippines healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Philippines healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Philippines healthcare market
Table of Contents
Product Code: GDHC0060CHR

Table of Contents

1.Table of Contents

  • 1.1 List of Figures
  • 1.2 List of Tables

2 Executive Summary

  • 2.1 Executive Summary - Overview
  • 2.2 Key Highlights
  • 2.3 Key Events: Philippines Pharmaceutical History, 2005-2019
  • 2.4 Key Events: Philippines Pharmaceutical Market
  • 2.5 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2018-2019
  • 2.6 Key Events: Mergers and Acquisitions
  • 2.7 Country Profile, Philippines, 2018

3 Overview of Pharmaceutical Market

  • 3.1 Pharmaceutical Market - Overview
  • 3.2 Pharmaceutical Market - Exports
  • 3.3 Pharmaceutical Market - Imports
  • 3.4 Pharmaceutical Market - Supply Channels
  • 3.5 Pharmaceutical Market - Market Segments
  • 3.6 Pharmaceutical Market - Major Therapeutic Areas
  • 3.7 Pharmaceutical Market - Major Players

4 Overview of Medical Devices Market

  • 4.1 Medical Device Market - Overview
  • 4.2 Medical Device Market - Top Five Segments
  • 4.3 Medical Device Market - Diagnostic Market
  • 4.4 Medical Device Market - Major Players

5 Pharmaceutical and Medical Device Market - Drivers and Barriers

  • 5.1 Drivers
  • 5.2 Barriers

6 Deal analysis

  • 6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Philippines
  • 6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Philippines

7 HealthTech Landscape

  • 7.1 HealthTech Deals Landscape, Philippines
    • 7.1.1 Key HealthTech Deals, Philippines
  • 7.2 Adoption of Technology in Healthcare, Philippines
    • 7.2.1 Key Developments: Technology in Healthcare, Philippines
  • 7.3 HealthTech Landscape- Philippines- Benefits and Risks

8 Pharmaceutical and Medical Device Market - Porter's Five Forces Analysis

  • 8.1 Pharmaceutical Market, Philippines - Porter's Five Forces Analysis
  • 8.2 Medical Device Market, Philippines - Porter's Five Forces Analysis

9 Market Access

  • 9.1 Overview of Healthcare System, Philippines
    • 9.1.1 Department of Health, Philippines
  • 9.2 Reimbursement of Medicinal Products, Philippines
  • 9.3 Overview of Health Insurance, Philippines
    • 9.3.1 Healthcare Spending and Health Price Index, Philippines
    • 9.3.2 Pricing Policies, Philippines
  • 9.4 Regulatory Landscape, Philippines
    • 9.4.1 Overview of Regulatory Agencies
    • 9.4.2 Market Authorization for Pharmaceutical Products, Philippines
    • 9.4.3 Market Authorization for Medical Devices, Philippines
    • 9.4.4 Intellectual Property Rights, Patent, Philippines
    • 9.4.5 Intellectual Property Rights, Trademark, Philippines
    • 9.4.6 Clinical Trial Regulations, Philippines
    • 9.4.7 Pharmaceutical Establishment Regulation, Philippines
    • 9.4.8 Exports and Imports, Philippines
    • 9.4.9 Pharmaceutical Advertising Regulations, Philippines
    • 9.4.10 Labeling and Packaging Regulations, Philippines

10 Country Healthcare Landscape

  • 10.1 Healthcare Policy Highlights
  • 10.2 Healthcare Facilities
  • 10.3 Healthcare Parameters
  • 10.4 Environmental Health
  • 10.5 Healthcare Personnel
  • 10.6 Disease Burden
  • 10.7 Healthcare Expenditure

11 Trade Associations, Philippines

12 Trade Fairs, Philippines

13 Opportunities and Challenges

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Coverage
    • 14.1.2 Secondary Research
    • 14.1.3 Forecasts
    • 14.1.4 Expert Panel
  • 14.2 Bibliography
  • 14.3 Contact Us

List of Tables

  • Table 1: Major Self-Medication Product Groups (Revenue, $M), Philippines, 2017
  • Table 2: Major Therapeutic Area by Pharmaceutical Sales (%), Philippines
  • Table 3: Medical Device Market, Philippines, Revenue by Segment, 2018
  • Table 4: Premium Contributions, Philippines, 2019-2025
  • Table 5: Benefit Payment, Philippines, 2018
  • Table 6: Private Insurance Providers, Philippines, 2018
  • Table 7: Regulatory Fees and Charges for Pharmaceutical Products, Philippines, 2019
  • Table 8: Classification of Medical Devices, Philippines, 2019
  • Table 9: Regulatory Fees and Charges for Medical Devices, Philippines, 2019
  • Table 10: Patent Fees, Philippines, 2019
  • Table 11: Patent Maintenance Fees, Philippines, 2019
  • Table 12: Trademark Fees, Philippines, 2019
  • Table 13: Trademark Maintenance Fees, Philippines, 2019
  • Table 14: Fees for LTO, Philippines, 2019
  • Table 15: Label of a Pharmaceutical Product, Philippines
  • Table 16: Minimum Particulars to Appear on Blisters or Strips
  • Table 17: Minimum Particulars to Appear on Primary Label of Small Containers

List of Figures

  • Figure 1: Pharmaceutical Market, Philippines, Revenue ($B), 2011-2018
  • Figure 2: Medical Device Market, Philippines, Revenue ($M), 2015-2028
  • Figure 3: Healthcare Startups in Philippines, Philippines, 2019
  • Figure 4: Number of Deals (2018-2019)
  • Figure 5: 2018-2019 Deal Overview By Region
  • Figure 6: Country Profile, Philippines, 2019
  • Figure 7: Pharmaceutical Market, Philippines, Revenue ($B), 2011-2018
  • Figure 8: Pharmaceutical Market, Philippines, Revenue Forecast ($B), 2019-2025
  • Figure 9: Pharmaceutical Market, Philippines, Pharmaceutical Exports, 2011-2018
  • Figure 10: Pharmaceutical Market, Philippines, Top Export Partners, 2018
  • Figure 11: Pharmaceutical Market, Philippines, Pharmaceutical Imports, 2011-2018
  • Figure 12: Pharmaceutical Market, Philippines, Top Import Partners, 2018
  • Figure 13: Utilization of Pharmaceutical Products by Value over Time (%), Philippines, 2010-2014
  • Figure 14: List of Reference Biotherapeutic Products, Philippines
  • Figure 15: Pharmaceutical OTC Market, Philippines, Revenue ($B), 2011-2018
  • Figure 16: Major Self-Medication Product Groups (Revenue, $M), Philippines, 2017
  • Figure 17: Pharmaceutical Market, Supply Chain, Philippines
  • Figure 18: Major Therapeutic Area by Pharmaceutical Sales (%), Philippines
  • Figure 19: Medical Device Market, Philippines, Revenue ($M), 2015-2018
  • Figure 20: Medical Device Market, Philippines, Revenue by Segment ($M), 2018
  • Figure 21: Medical Device Market, Philippines, Revenue ($B) of Major Companies, 2018
  • Figure 22: Deal Value and Deal Count, Pharmaceutical Market, Philippines, 2018-2019
  • Figure 23: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Philippines, 2018-2019
  • Figure 24: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Philippines, 2018-2019
  • Figure 25: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Philippines, 2018-2019
  • Figure 26: Deal Value, HealthTech, Philippines, 2018-2019
  • Figure 27: Deal Count, HealthTech, Philippines, 2018-2019
  • Figure 28: National eHealth Capacity Roadmap, Philippines
  • Figure 29: Overview of Healthcare System, Philippines, 2019
  • Figure 30: Department of Health, Philippines, 2019
  • Figure 31: Classification into Core and Complementary Medicines, Philippines
  • Figure 32: Selection of Medicines for Inclusion in the PNF, Philippines
  • Figure 33: NHIP Members Covered by Sector, 2018
  • Figure 34: OOP Expenditure (% of total expenditure on health), Philippines, 2011-2016
  • Figure 35: Annual Rate of Change (%), Health Price Index, Philippines, 2011-2017
  • Figure 36: Price Regulation, Philippines, 2019
  • Figure 37: Philippines FDA, Organizational Structure, Philippines, 2019
  • Figure 38: Drug Registration Process, Philippines, 2019
  • Figure 39: New Drug Registration Requirements, Philippines, 2019
  • Figure 40: Generic Drug Registration Requirements, Philippines, 2019
  • Figure 41: Technical Requirements for Authorization of Medical Devices, Philippines, 2019
  • Figure 42: Authorization of Medical Devices, Philippines, 2019
  • Figure 43: Patent Approval Process, Philippines, 2019
  • Figure 44: Trademark Approval Process, Philippines, 2019
  • Figure 45: Pharmaceutical Clinical Trials Count By Trial Status, Philippines, 2018-2019
  • Figure 46: Pharmaceutical Clinical Trials Count By Phase, Philippines, 2018-2019
  • Figure 47: Pharmaceutical Clinical Trials Count By Therapy Area, Philippines, 2018-2019
  • Figure 48: Top Five Pharmaceutical Clinical Trials Sponsor By Count, Philippines, 2018-2019
  • Figure 49: Medical Devices Clinical Trials Count By Therapy Area, Philippines, 2018-2019
  • Figure 50: Medical Devices Clinical Trials Count By Trial Status, Philippines, 2018-2019
  • Figure 51: Clinical Trial Approval Process, Philippines, 2019
  • Figure 52: License to Operate, Philippines, 2019
  • Figure 53: Export Procedure, Philippines, 2019
  • Figure 54: Import Procedure, Philippines, 2019
  • Figure 55: Number of Hospitals, Philippines, 2011-2015
  • Figure 56: Diagnostic Equipment (per million population), Philippines, 2010-2013
  • Figure 57: Government Hospital Beds, Philippines
  • Figure 58: Government Hospital Beds, Philippines
  • Figure 59: Hospital Beds (per 10,000 population), Philippines
  • Figure 60: Life Expectancy, 2011-2017, Philippines
Back to Top